Skip to main content
. 2022 Nov 9;24(12):1587–1597. doi: 10.1111/jch.14593

FIGURE 1.

FIGURE 1

Hazard ratios for CV mortality for patients receiving (A) no ACE inhibitors, no ARB, no aldosterone blockers, (B) ACE inhibitors but no ARB, no aldosterone blockers and (C) no ACE inhibitors, no aldosterone blockers, but ARB. Cox proportional hazards regression for Z‐transformed variables with adjustment for age and sex